Clinical Trials Directory

Trials / Completed

CompletedNCT03231774

Comparability of Hemodynamic Parameters Measured by Non-invasive Echocardiography and by Right Heart Catheterization

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Heart and Diabetes Center North-Rhine Westfalia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is to compare transthoracic Echocardiography TTE to the gold standard Right Heart Catheterization in Terms of accuracy to measure hemodynamic parameters.

Detailed description

Chronic heart failure is a progressive disease in Western population. Echocardiography and right heart catheterization are important tools in the diagnosis and progress monitoring of heart failure. Gold standard in diagnosis of hemodynamic parameters in patients with heart failure is right heart catheterization. However, this diagnostic device represents an invasive method that is additionally associated with high risks such as infections, vessel and nerve injuries. Echocardiography is probably in a position to determine hemodynamic parameters as reliably as right heart catheterization without additional health risk due to its non-invasive character. All procedures performed are part of clinical Routine. Patients do not undergo any study-specific procedure at all.

Conditions

Timeline

Start date
2017-07-21
Primary completion
2017-12-31
Completion
2018-07-31
First posted
2017-07-27
Last updated
2020-10-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03231774. Inclusion in this directory is not an endorsement.